Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 8,153 | 59,660,184 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
| Healthcare | HEALTHCARE | Sector | 1,332 | 6,612,521 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.07% | 1.91% | 4.34% | -1.11% | 23.67% | 30.73% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 309 | 1,574,627 | 0.13% | 2.15% | 4.25% | 0.24% | 22.96% | 18.88% |
| Immunology Biopharmaceuticals | IMMUNOLOGY | SubInd | 31 | 320,460 | 0.99% | 3.42% | 1.46% | -3.72% | 22.83% | 28.92% |
Show Stocks
Sort: #Stocks
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,717 | 77,876,547 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
| Immunology Biopharmaceuticals | IMMUNOLOGY | SubInd | 31 | 320,460 | 0.99% | 3.42% | 1.46% | -3.72% | 22.83% | 28.92% |
| TG Therapeutics, Inc. | TGTX:USATGTX:USA | Stock | 1 | 2,547 | -5.40% | -0.84% | 17.80% | 24.57% | 46.36% | -46.21% |
| AbbVie, Inc. | ABBV:USAABBV:USA | Stock | 1 | 293,852 | 1.26% | 3.53% | 1.07% | -4.42% | 22.63% | 20.73% |
| Aurinia Pharmaceuticals, Inc. | AUPH:USAAUPH:USA | Stock | 1 | 828 | -0.17% | 14.74% | 19.75% | 3.04% | -29.41% | -46.37% |
| Astria Therapeutics, Inc. | ATXS:USAATXS:USA | Stock | 1 | 524 | 1.17% | -1.95% | -9.49% | -31.61% | 111.06% | -24.11% |
| Viridian Therapeutics, Inc. | VRDN:USAVRDN:USA | Stock | 1 | 858 | -8.07% | -3.24% | -11.28% | -30.06% | -11.51% | -40.41% |
| Alpine Immune Sciences, Inc. | ALPN:USAALPN:USA | Stock | 1 | 4,259 | 0.02% | 0.05% | 0.84% | 112.95% | 413.19% | 655.47% |
| Kiniksa Pharmaceuticals Ltd. | KNSA:USAKNSA:USA | Stock | 1 | 1,313 | -1.69% | 1.23% | 17.12% | -0.75% | 27.55% | 49.66% |
| Cabaletta Bio, Inc. | CABA:USACABA:USA | Stock | 1 | 596 | -2.14% | 9.68% | -11.60% | -45.59% | -29.19% | 0.41% |
| Immunovant, Inc. | IMVT:USAIMVT:USA | Stock | 1 | 4,454 | -2.48% | 4.46% | 8.40% | -18.13% | -8.96% | 44.61% |
| Alvotech | ALVO:USAALVO:USA | Stock | 1 | 3,602 | 0.00% | 0.97% | 4.73% | -15.47% | 49.50% | 63.04% |
| BioCryst Pharmaceuticals, Inc. | BCRX:USABCRX:USA | Stock | 1 | 1,296 | -2.94% | 18.05% | 39.56% | 7.90% | 22.18% | -24.97% |
| Kyverna Therapeutics, Inc. | KYTX:USAKYTX:USA | Stock | 1 | 665 | 1.11% | 10.14% | -18.88% | -45.34% | N/A | N/A |
| Pharvaris NV | PHVS:USAPHVS:USA | Stock | 1 | 1,064 | -6.26% | -5.17% | 10.48% | -24.96% | 30.37% | 131.25% |
| Vera Therapeutics, Inc. | VERA:USAVERA:USA | Stock | 1 | 2,254 | -1.31% | 0.17% | 4.84% | -7.38% | 213.09% | 459.32% |
* Colors indicate performance relative to the benchmark.